Substance Use Tied to Acute Cardiovascular Events During Delivery
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 22, 2023 -- Substance use has a strong association with acute cardiovascular events and maternal mortality during hospitalization for delivery, according to a study published in the October issue of JACC: Advances.
Kari Evans, M.D., from the University of Arizona in Phoenix, and colleagues examined the association between substance use and acute cardiovascular events in pregnancy. The analysis included women with a delivery hospitalization between 2004 and 2018 identified through the Nationwide Inpatient Sample (955,531 individuals with substance use).
The researchers found that substance use was independently associated with cardiovascular events (adjusted odds ratio, 1.61), major adverse cardiac events (adjusted odds ratio, 1.53), and maternal mortality (adjusted odds ratio, 2.65) during delivery hospitalization. For cardiovascular events, all individual substances had an increased association; however, the association was strongest for amphetamine/methamphetamine (adjusted odds ratio, 2.71). For maternal death, all substances other than cocaine and cannabis had a significant association.
"As substance use continues to increase in pregnant women and maternal mortality continues to rise, these findings have important implications for maternal health," the authors write. "Further work is needed to address maternal care in this population, including an effective national policy to address this growing public health issue."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
American College of Obstetricians and Gynecologists, May 17-19
The annual meeting of the American College of Obstetricians and Gynecologists was held from May 17 to 19 in San Francisco and was attended by more than 4,000 clinicians...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.